Yeul Hong Kim, MD
Articles
Epirubicin, Cisplatin, Oral UFT, and Calcium Folinate in Advanced Gastric Carcinoma
Yeul Hong Kim, MD;Byung Soo Kim, MD;Jae Hong Seo, MD;Cheol Won Choi, MD;Jun Suk Kim, MD;Jae Sun Kim, MD;Hoon Jai Chun, MD;Jin Hai Hyun, MD
July 1st 1999UFT (uracil and tegafur in a 4:1 molar ratio) plus calcium folinate treatment has favorable activity and tolerable toxicity in patients with advanced gastric carcinoma. High response rates have been reported in patients with
Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma
Yeul Hong Kim, MD;Sang Won Shin, MD;Byung Soo Kim, MD;Young Tae Park, MD;Jongguk Kim, MD;Jun Suk Kim, MD
September 2nd 1997Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided
Latest Updated Articles
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: December 1st 2016 | Updated: December 22nd 2024
Patient With History of COPD Presents With Abdominal Pain
Published: August 26th 2011 | Updated: December 22nd 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
